Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Micro Interventional Devices Inc.

www.microinterventional.com

Latest From Theramex SPA

EMA Warning For Ariad’s Iclusig, While CHCs Get The Benefit Of The Doubt

EMA doesn’t suspend, but warns on Ariad’s leukemia drug Iclusig for potential blood clots, while saying combined hormonal contraceptives’ benefit outweighs their risk.

BioPharmaceutical Europe

Deals Shaping the Medical Industry (12/2010)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Micro Interventional Devices Inc.
  • Senior Management
  • Michael P Whitman, Pres. & CEO
    Willard Hennemann, PhD, CSO
    Linda Morgan, SVP, Operations
  • Contact Info
  • Micro Interventional Devices Inc.
    Phone: (215) 600-1270
    5 Caufield Pl.
    Ste. 102
    Newtown, PA 18940
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register